Kevin M. Lalande is Director of LUMOS PHARMA, INC.. Currently has a direct ownership of 1,076 shares of LUMO, which is worth approximately $2,345. The most recent transaction as insider was on May 20, 2021, when has been sold 367 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.08K
0% 3M change
0% 12M change
Total Value Held $2,345

KEVIN M. LALANDE Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2021
BUY
Grant, award, or other acquisition
-
367 Added 25.43%
1,076 Common Stock

Also insider at

MTEM
Molecular Templates, Inc. Healthcare
KML

Kevin M. Lalande

Director
Austin, TX

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO